CIK 0001417663 · Non-accelerated filer<br>Smaller reporting company
SANUWAVE Health, Inc.
Sign in to watch- Ticker
- SNWV
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 201176000
- Phone
- 952-656-1029
- Business address
- 9600 W. 76TH STREET, EDEN PRAIRIE, MN
- Former names
- RUB MUSIC ENTERPRISES, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-15 | Cioanta Iulian Chief Sci. and Tech. Officer | Option exercise | +1,777 | $14.20 | $25K | 1,818 |
| 2025-05-15 | Cioanta Iulian Chief Sci. and Tech. Officer | Option exercise | +529 | $22.50 | $12K | 2,347 |
| 2025-05-15 | Cioanta Iulian Chief Sci. and Tech. Officer | Option exercise | +1,333 | $15.00 | $20K | 3,680 |
| 2025-05-15 | Cioanta Iulian Chief Sci. and Tech. Officer | Sale | −3,639 | $31.60 | $115K | 41 |
| 2025-05-15 | Cioanta Iulian Chief Sci. and Tech. Officer | Option exercise · Stock Option (right to buy) | −1,777 | 8,890 | ||
| 2025-05-15 | Cioanta Iulian Chief Sci. and Tech. Officer | Option exercise · Stock Option (right to buy) | −529 | 0 | ||
| 2025-05-15 | Cioanta Iulian Chief Sci. and Tech. Officer | Option exercise · Stock Option (right to buy) | −1,333 | 0 | ||
| 2025-04-29 | Opaleye Management Inc. 10% owner | Purchase | +5,000 | $25.49 | $127K | 965,000 |
| 2025-04-29 | Opaleye Management Inc. 10% owner | Purchase | +2,998 | $25.49 | $76K | 15,000 |
| 2025-04-03 | Stolarski Anthony Michael Director | Grant or award · Stock Option (right to buy) | +1,761 | 1,761 | ||
| 2025-04-03 | Tyler James Director | Grant or award · Stock Option (right to buy) | +1,761 | 1,761 | ||
| 2025-04-03 | Blizard Jeffrey Director | Grant or award · Stock Option (right to buy) | +1,761 | 1,761 | ||
| 2025-04-03 | Miller Ian D. Director | Grant or award · Stock Option (right to buy) | +1,981 | 1,981 | ||
| 2025-04-03 | FRANK MORGAN C. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,761 | 1,761 | ||
| 2025-01-31 | FRANK MORGAN C. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-01-31 | Gilmore Nanci Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +1,571 | $15.67 | $25K | 1,571 |
| 2025-01-31 | Sorensen Peter Chief Financial Officer | Grant or award · Stock Option (right to buy) | +260 | $15.67 | $4K | 260 |
| 2025-01-08 | Wern David Timothy Executive VP of Sales | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-12-31 | Stolarski Anthony Michael Director | Grant or award · Stock Option (right to buy) | +1,559 | 1,559 | ||
| 2024-12-31 | Miller Ian D. Director | Grant or award · Stock Option (right to buy) | +1,754 | 43,087 |
Page 4 of 16 · 302 trades